EMEA-002773-PIP01-20-M01
Submitted by Anonymous (not verified) on 13 September 2024 - 9:40
EMEA-002773-PIP01-20-M01
EMEA-002699-PIP01-19-M01
Submitted by Anonymous (not verified) on 13 September 2024 - 9:36
EMEA-002699-PIP01-19-M01
EMEA-002677-PIP01-19-M03
Submitted by Anonymous (not verified) on 13 September 2024 - 9:30
EMEA-002677-PIP01-19-M03
EMEA-002653-PIP01-19-M01
Submitted by Anonymous (not verified) on 13 September 2024 - 9:27
EMEA-002653-PIP01-19-M01
EMEA-002635-PIP02-21-M02
Submitted by Anonymous (not verified) on 13 September 2024 - 9:09
EMEA-002635-PIP02-21-M02
Opinion/decision on a Paediatric investigation plan (PIP): Verzenios, abemaciclib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0313/2023
Submitted by Anonymous (not verified) on 13 September 2024 - 9:00
Opinion/decision on a Paediatric investigation plan (PIP): Verzenios, abemaciclib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0313/2023
Opinion/decision on a Paediatric investigation plan (PIP): Verzenios, abemaciclib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0312/2023
Submitted by Anonymous (not verified) on 13 September 2024 - 8:57
Opinion/decision on a Paediatric investigation plan (PIP): Verzenios, abemaciclib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0312/2023
Opinion/decision on a Paediatric investigation plan (PIP): Lynparza, Olaparib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0320/2023
Submitted by Anonymous (not verified) on 13 September 2024 - 8:53
Opinion/decision on a Paediatric investigation plan (PIP): Lynparza, Olaparib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0320/2023
Opinion/decision on a Paediatric investigation plan (PIP): Leqvio, Inclisiran sodium, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Endocrinology-Gynaecology-Fertility-Metabolism, PIP number: P/0322/20
Submitted by Anonymous (not verified) on 13 September 2024 - 8:51
Opinion/decision on a Paediatric investigation plan (PIP): Leqvio, Inclisiran sodium, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Endocrinology-Gynaecology-Fertility-Metabolism, PIP number: P/0322/2023
Opinion/decision on a Paediatric investigation plan (PIP): Imjudo, Tremelimumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0302/2023
Submitted by Anonymous (not verified) on 13 September 2024 - 8:49
Opinion/decision on a Paediatric investigation plan (PIP): Imjudo, Tremelimumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Oncology, PIP number: P/0302/2023